Monitor utilization of the RPA facility in upcoming quarters – heavy use may signal working capital strain, while moderate use could improve cash conversion. The uncommitted nature limits downside risk but also makes the liquidity source uncertain.
Price Chart
Executive Summary
Hims & Hers Health entered into a $400M uncommitted receivables purchase facility with JPMorgan Chase, allowing its pharmacy subsidiaries to sell eligible receivables for cash. The company also amended its existing credit agreement to permit the facility and related transactions, adding a $400M indebtedness basket for the receivables purchase program.
Key Facts
- Master Receivables Purchase Agreement (RPA) with JPMorgan provides up to $400M facility limit for eligible receivables.
- Facility is uncommitted – JPMorgan may decline to purchase receivables at its sole discretion.
- Initial term of 364 days, extendable by mutual agreement for additional one-year periods.
- Amendment No. 4 to existing Credit Agreement permits the RPA and adds a $400M permitted indebtedness basket for receivables purchase programs.
- Hims & Hers has provided a Performance Undertaking guaranteeing sellers' performance under the RPA, but not the collectability of receivables.
Financial Impact
Up to $400 million in additional liquidity through sale of receivables, though uncommitted and at JPMorgan's discretion.
Risk Factors
- JPMorgan may decline to purchase receivables at any time, making the facility unreliable for crucial funding.
- If heavily utilized, the facility could increase effective leverage, though structured as a sale of receivables.
- Potential for higher financing costs if credit spreads widen.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001773751-26-000146 |
| Document: a102amendmentno4tocreditag.htm | 0001773751-26-000146 |
| Document: hims-20260626.htm | 0001773751-26-000146 |
| Document: 0001773751-26-000146-index-headers.html | 0001773751-26-000146 |
| Document: 0001773751-26-000146-index.html | 0001773751-26-000146 |
| Document: 0001773751-26-000146.txt | 0001773751-26-000146 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | 8-K | $28.06 | awaiting T+20 | — | $28.19 (+0.46%) |
Sep 23, 2026 4w ago | Insider Cluster | $29.28 $29.13 | ▲ +0.51% | ▲ +0.09% | $28.19 (+3.72%) |
Sep 18, 2026 5w ago | Insider Cluster | $29.35 $28.15 | ▲ +4.09% | ▲ +3.18% | $28.19 (+3.95%) |
Sep 17, 2026 5w ago | Insider Cluster | $27.99 $28.07 | ▼ −0.29% | ▼ −0.08% | $28.19 (−0.71%) |
Aug 20, 2026 9w ago | Insider Cluster | $33.78 $29.35 | ▼ −13.11% | ▼ −14.13% | $28.19 (−16.55%) |
Aug 20, 2026 9w ago | Insider Cluster | $33.78 $29.35 | ▼ −13.11% | ▼ −14.13% | $28.19 (−16.55%) |
Aug 18, 2026 9w ago | Insider Cluster | $31.09 $27.89 | ▼ −10.29% | ▼ −9.45% | $28.19 (−9.33%) |
Aug 10, 2026 11w ago | 8-K | $30.51 $27.90 | ▼ −8.55% | ▼ −7.50% | $28.19 (−7.60%) |
Jul 1, 2026 16w ago | 8-K | $36.80 $27.04 | ▼ −26.52% | ▼ −26.11% | $28.19 (−23.40%) |
Jun 17, 2026 18w ago | Insider Cluster | $35.47 $33.68 | ▼ −5.05% | ▼ −5.58% | $28.19 (−20.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers